2020
DOI: 10.1101/2020.03.28.013755
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Population structure and pharmacogenomic risk stratification in the United States

Abstract: Pharmacogenomic (PGx) variants mediate how individuals respond to medication, and response differences among racial/ethnic groups have been attributed to patterns of PGx diversity. We hypothesized that genetic ancestry (GA) would provide higher resolution for stratifying PGx risk, since it serves as a more reliable surrogate for genetic diversity than self-identified race/ethnicity (SIRE), which includes a substantial social component. We analyzed a cohort of 8,628 individuals from the United States (US), for … Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 68 publications
0
1
0
Order By: Relevance
“…This has important implications when evaluating drug response and for pharmacogenetic studies in Hispanics. Compared with other major populations, Hispanics typically have the highest composition of Native American genetic ancestry, and may report “other” race when demographic data are collected in this manner 27,28 . This may limit the identification of genetic influences that may be unique to Hispanics due to higher Native American ancestry, and this should be considered when conducting future studies.…”
Section: Pharmacogenomic Actionability – Implications By Race/ancestrymentioning
confidence: 99%
“…This has important implications when evaluating drug response and for pharmacogenetic studies in Hispanics. Compared with other major populations, Hispanics typically have the highest composition of Native American genetic ancestry, and may report “other” race when demographic data are collected in this manner 27,28 . This may limit the identification of genetic influences that may be unique to Hispanics due to higher Native American ancestry, and this should be considered when conducting future studies.…”
Section: Pharmacogenomic Actionability – Implications By Race/ancestrymentioning
confidence: 99%